Scott McAuley
Stock Analyst at Paradigm
(0.24)
# 4,397
Out of 4,592 analysts
17
Total ratings
15.8%
Success rate
-19.7%
Average return
Main Sectors:
Stocks Rated by Scott McAuley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Maintained: Buy | $1.50 → $0.95 | $0.30 | +222.03% | 4 | Apr 8, 2026 | |
| NGEN NervGen Pharma | Maintained: Buy | $6.9 | $1.62 | n/a | 3 | Jun 17, 2025 | |
| TSX: GUD Knight Therapeutics Inc. | Maintained: Hold | $7.50 → $5.30 | $9.84 | n/a | 3 | May 15, 2023 | |
| ZYME Zymeworks | Maintained: Buy | $24 → $15 | $21.94 | n/a | 4 | May 15, 2023 | |
| TSX: EDT Spectral Medical Inc. | Maintained: Buy | n/a | $1.39 | n/a | 1 | Apr 7, 2022 | |
| VPHIF Valeo Pharma Inc. | Maintained: Buy | $1.64 | $0.000001 | n/a | 2 | Feb 3, 2022 |
Perimeter Medical Imaging AI, Inc.
Apr 8, 2026
Maintained: Buy
Price Target: $1.50 → $0.95
Current: $0.30
Upside: +222.03%
NervGen Pharma
Jun 17, 2025
Maintained: Buy
Price Target: $6.9
Current: $1.62
Upside: n/a
Knight Therapeutics Inc.
May 15, 2023
Maintained: Hold
Price Target: $7.50 → $5.30
Current: $9.84
Upside: n/a
Zymeworks
May 15, 2023
Maintained: Buy
Price Target: $24 → $15
Current: $21.94
Upside: n/a
Spectral Medical Inc.
Apr 7, 2022
Maintained: Buy
Price Target: n/a
Current: $1.39
Upside: n/a
Valeo Pharma Inc.
Feb 3, 2022
Maintained: Buy
Price Target: $1.64
Current: $0.000001
Upside: n/a